Top News Online

Courtesy of Gilead Gilead Science’s Sovaldi (Sofosbuvir) has received government approval for the treatment of chronic hepatitis C, meaning some patients will not have to deal with the severe side effects of the injected drug interferon. U.S. regulators on Friday approved Gilead Sciences Inc’s Sovaldi, also known as sofosbuvir, as a potential cure for chronic infection with the liver-destroying hepatitis ...

Read More »